Skip to main content
Premium Trial:

Request an Annual Quote

Startup SpinDiag Raises €1.6M in Seed Funding

NEW YORK (GenomeWeb) – German start-up SpinDiag said on Thursday that it has raised €1.6 million ($1.9 million) in seed funding.

The financing came from three unnamed private investors and will be used to bring its point-of-care screening system to hospitals from its current laboratory environment, the firm said. The technology called SpinDiag one, is being developed for hospital screening of all clinically relevant antibiotic-resistant bacteria at the time patients are admitted.

According to SpinDiag's website, the platform will be able to detect such bacteria in 30 minutes directly from patient samples and will enable the parallel identification of some of the most prevalent drug-resistant pathogens, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, and carbapenemase producers.

The system uses centrifugal microfluidic technology to provide laboratory-grade PCR results and has an automated workflow, the company siad.

"The platform characteristic of our product enables a very powerful product pipeline for the point-of-care testing of infectious diseases, such as respiratory tract infections, sepsis, and tuberculosis," Oliver Strohmeier, SpinDiag's cofounder and chief technology officer, said in a statement.

Based in Freiburg, SpinDiag was spun out of the research institute Hahn-Schickard in 2016. 

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.